Sacubitril-Valsartan-Mepha 24 mg/26 mg
Sacubitril-Valsartan-Mepha 24 mg/26 mg is a medicine authorised by Swissmedic under authorisation number 69813. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 11 December 2025 and the authorisation is limited until 10 December 2030. ATC code C09DX04 places the medicine in the group Agents acting on the renin-angiotensin system.
| Authorisation number | 69813 |
|---|---|
| Name | Sacubitril-Valsartan-Mepha 24 mg/26 mg |
| Full name | Sacubitril-Valsartan-Mepha 24 mg/26 mg, Filmtabletten |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | C09DX04 |
| First authorisation | 11 December 2025 |
| Authorisation validity | 10 December 2030 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Sacubitril-Valsartan-Mepha 24 mg/26 mg, Filmtabletten | B | 11 December 2025 |
| 2 | Sacubitril-Valsartan-Mepha 49 mg/51 mg, Filmtabletten | B | 11 December 2025 |
| 3 | Sacubitril-Valsartan-Mepha 97 mg/103 mg, Filmtabletten | B | 11 December 2025 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 28 | Tablette(n) | C09DX04 | 02.07.2. | B |
| 2 | 56 | Tablette(n) | C09DX04 | 02.07.2. | B |
| 3 | 56 | Tablette(n) | C09DX04 | 02.07.2. | B |
| 4 | 168 | Tablette(n) | C09DX04 | 02.07.2. | B |
| 5 | 56 | Tablette(n) | C09DX04 | 02.07.2. | B |
| 6 | 168 | Tablette(n) | C09DX04 | 02.07.2. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Sacubitril-Valsartan-Mepha 24 mg/26 mg authorised in Switzerland?
Yes. Sacubitril-Valsartan-Mepha 24 mg/26 mg is authorised by Swissmedic under authorisation number 69813, data as of 01 September 2026. The authorisation is limited until 10 December 2030.
Which dispensing category does Sacubitril-Valsartan-Mepha 24 mg/26 mg have?
Sacubitril-Valsartan-Mepha 24 mg/26 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Sacubitril-Valsartan-Mepha 24 mg/26 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.